Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL.
暂无分享，去创建一个
Michael L. Wang | L. Gordon | D. Maloney | M. Lunning | N. Ghosh | E. Purev | T. Siddiqi | C. Andreadis | J. Abramson | A. Forero-Torres | M. Palomba | S. Solomon | J. Arnason | A. Sehgal | Jacob Garcia | B. Xie | T. Albertson